HCPLive Network


The US Food and Drug Administration (FDA) approved Bexsero, a Novartis vaccine to prevent meningococcal disease caused by Neisseria meningitides serogroup B. It is meant for children age 10 and up and young adults through age 25.
The US Department of Health and Human Services (HHS) plans to spend $2.7 billion in emergency funds to counter the spread of Ebola. On Jan. 13 the agency detailed its spending plans. Spending categories range from over a half billion dollars for international projects to a half million dollars for regulatory work that includes monitoring for fraudulent Ebola products.Separately, on the international front, J&J Pharmaceuticals announced it has formed an Ebola vaccine development group with international funding of 100 million euros.
Though the flu vaccine for the 2014-2015 season is only 23% effective, the US Centers for Disease Control and Prevention (CDC) continues to recommend flu shots for those who do not have the illness, and antivirals for those who do. The effectiveness estimate is based on data from 2,321 children and adults with acute respiratory illness tested from Nov. 10, 2014 to Jan. 2, 2015 at 5 study sites with outpatient facilities. The cases were all laboratory confirmed.
Widespread vaccination against rotavirus cuts children's rates of infection, according to a new study funded by the US Centers for Disease Control and Prevention and published online Jan. 12 in Pediatrics.
The 2014-2015 flu season has been one of the worst on record in recent years and now the US Food and Drug Administration has approved a waiver allowing a test to be more widely when confirming a diagnosis of influenza virus infection.
The rapid growth of severe allergies and anaphylaxis in populations around the world has triggered efforts to find faster, safer and more effective cures than conventional immunotherapy.
Vaccination Upcoming Events
Vaccination Latest News
Vaccination Clinical Trials
Vaccination Resources